Eur Rev Med Pharmacol Sci 2020; 24 (24): 12625-12625
DOI: 10.26355/eurrev_202012_24143

MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3

J. Wang, J. Guo, H. Fan

Department of Hepatobiliary Surgery, Huangshi Central Hospital of the Eastern Hubei Medical Group, Huangshi, Hubei, China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3, by J. Wang, J. Guo, H. Fan, published in Eur Rev Med Pharmacol Sci 2019; 23 (12): 5168-5175–DOI: 10.26355/eurrev_201906_18181–PMID: 31298410” has been withdrawn.
The authors stated that the problem was related to “substantial deficiency in the experimental design (Figures 3B and 4C, 4E, and 4F). The experiment was not done well at that time. It was processed by computer and there were some inaccuracies”.

The Publisher apologizes for any inconvenience this may cause.

MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3

Free PDF Download

To cite this article

J. Wang, J. Guo, H. Fan
MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 24
Pages: 12625-12625
DOI: 10.26355/eurrev_202012_24143